Stocks · Healthcare · Drug Manufacturers - Specialty & Generic
Glass House Brands Inc GLAS
$5.49 +3.20% Close, Oct 2, 2026 · NYSE · Market cap $422.7M
Next earnings report: Nov 11, 2026
Scroll or pinch to zoom, drag to move. Daily prices adjusted for splits. Markers: E = earnings (green beat, red miss), S = split, D = dividend.
Three things to know
- The stock is 60% below its highest close of the past year.
PromtFinance scores
Each score is a percentile within the Healthcare sector (0–100). Under each score: how the stock ranks in its sector on every component. As of Oct 5, 2026.
How fast revenue, earnings and cash flow are growing.
Returns on capital, margins, earnings quality and balance-sheet strength.
- Return on invested capitalTop 45%
- Gross marginBottom 21%
- Operating marginBottom 41%
- Accruals (lower is better)Top 36%
- Interest coverBottom 33%
How cheap the shares are relative to earnings, cash flow and their own history.
- Earnings yieldBottom 42%
- Free-cash-flow yieldBottom 40%
- EBITDA / enterprise valueTop 50%
- Sales / enterprise valueTop 38%
Strength and persistence of the price trend, including versus the S&P 500.
Earnings surprises and analyst sentiment (estimate-revision history is being collected).
- Average EPS surprise, last 4 quartersBottom 38%
- Consecutive EPS beatsBottom 20%
- Upside to consensus price targetTop 21%
Low volatility, shallow drawdowns, low market sensitivity and modest leverage.
- Volatility, 60 days (lower is better)Bottom 30%
- Maximum drawdown, 3 yearsTop 37%
Fundamental momentum
| Measure | Now (TTM) | Year / quarter before | Sector rank | |
|---|---|---|---|---|
| Gross margin | 33.1% | — | Bottom 21% | |
| Operating margin | -24.4% | — | Bottom 41% | |
| Net margin | -31.0% | — | — | |
| Free-cash-flow margin | -22.7% | — | — | |
| Return on invested capital | -14.4% | — | Top 45% |
Quality of earnings and balance sheet
- Accruals (net income − OCF) / assetsLower is better; high accruals can signal weaker earnings quality.
- -9.7%
- Stock-based compensation / revenueA cost to shareholders through dilution.
- 10.5%
- Interest cover (operating income / interest)How many times operating profit covers interest.
- -10.1×
Shareholder returns
- Dividend yield (dividends paid, TTM)
- 0.68%
- Net buyback yield (TTM)
- -5.51%
- Shareholder yield
- -4.83%
Shareholder yield = dividends + net buybacks over the last four quarters, divided by market cap.
Based on the four quarters through Jun 30, 2026 (filed Aug 14, 2026).
Earnings and expectations
Earnings momentum
- Consecutive EPS beats
- 0
- Beats in the last 8 reports
- 3 of 8
- Average EPS surprise, last 4
- -2.8%
- Average 2-day reaction, last 8
- +3.1%
- Positive 20 days after report
- 0 of 1
Analysts
- Consensus price target
- $16.00
- Target vs current price
- +191.4%
How the stock reacted to recent reports
| Report date | EPS surprise | 2 days | 5 days | 20 days | 60 days |
|---|---|---|---|---|---|
| Aug 12, 2026 | -4.3% | +3.1% | -6.2% | -18.4% | — |
Returns from the close before each report. Past reactions do not determine future ones.
Earnings history
| Report date | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|
| Aug 12, 2026 | -$0.08 | -$0.08 | -4.3% | $47.0M |
| May 13, 2026 | -$0.20 | -$0.18 | -14.3% | $40.5M |
| Mar 24, 2026 | -$0.20 | -$0.19 | -6.7% | $38.9M |
| Nov 12, 2025 | -$0.15 | -$0.18 | +14.3% | $38.4M |
| Aug 13, 2025 | $0.05 | -$0.05 | +191.7% | $59.9M |
| May 13, 2025 | -$0.18 | -$0.15 | -24.1% | $44.8M |
| Mar 25, 2025 | $0.16 | -$0.10 | +249.6% | $53.0M |
| Nov 13, 2024 | -$0.09 | $0.01 | -1900.0% | $63.8M |
Valuation in context
| Multiple | Now | 5-year median | 5-year percentile | Sector rank (cheapness) |
|---|---|---|---|---|
| EV / Sales | 2.92× | — | — | Top 38% |
| Free-cash-flow yield | -8.76% | — | — | Bottom 40% |
| Earnings yield | -11.76% | — | — | Bottom 42% |
Technical state
Trend checklist
- ✗ Price above 20-day average
- ✗ Price above 50-day average
- ✗ MACD histogram positive
Trend quality
- Days above the 50-day average
- 0
- 50-day average slope (20 days)
- -15.5%
- Distance from 50-day average
- -37.6%
- RSI (14)
- 19.3
- Relative volume
- 1.09×
Risk and drawdowns
- Volatility, 60 days (annualized)
- 68.4%
- Current drawdown from 1-year high
- -59.9%
- Maximum drawdown, 3 years
- -61.2%
Largest declines in the past six years
| From peak | To low | Decline | Length | Recovery |
|---|---|---|---|---|
| Jun 18, 2026 | Oct 1, 2026 | -61.2% | 72 days | Not yet recovered |
Declines of 10% or more from a closing high, measured on daily closes.
Financial statements
- Market cap
- $422.7M
- EPS, diluted (TTM)
- -$0.65
- Revenue (TTM)
- $163.2M
| FY 2025 | |
|---|---|
| Revenue | $182.0M |
| Gross profit | $77.0M |
| Operating income | -$14.6M |
| Net income | -$29.7M |
| EPS (diluted) | -$0.55 |
| Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
|---|---|---|---|---|
| Revenue | $38.4M | $38.9M | $38.9M | $47.0M |
| Net income | -$12.3M | -$16.0M | -$15.5M | -$6.8M |
| EPS (diluted) | -$0.19 | -$0.19 | -$0.18 | -$0.09 |
| FY 2025 | |
|---|---|
| Operating cash flow | $11.4M |
| Capital expenditure | -$27.2M |
| Free cash flow | -$15.7M |
| Dividends paid | $0 |
| Net share buybacks | -$15.3M |
Cash outflows are shown as negative numbers.
- Cash and short-term investments
- $18.6M
- Total assets
- $313.4M
- Total liabilities
- $148.2M
- Total debt
- $72.3M
- Net debt
- $53.8M
- Shareholders’ equity
- $72.6M
As of Jun 30, 2026 (filed Aug 14, 2026).
Short interest
- Shares sold short
- 199,756
- Days to cover
- 1.00
- Change vs previous report
- +8.6%
FINRA short interest, settlement date Sep 15, 2026.